[Malformations of cortical development and epilepsy]

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Approximately 15% of childhood epilepsies are resistant to antiepileptic drugs.
• Malformations of cortical development (MCD) account for 40% of these drug-resistant cases.
• Existing MCD classifications focus on developmental steps, but a clinic-molecular approach is needed.

Purpose of the Study:

• To propose a new classification for malformations of cortical development (MCD).
• To correlate MCD subtypes with genetic pathways, imaging phenotypes, and clinical presentations.
• To highlight the importance of prompt diagnosis for improving outcomes in pediatric epilepsy.

Main Methods:

• Review and synthesis of current literature on MCD classification.
• Integration of clinical, molecular, and imaging data.
• Categorization of MCD into four main groups based on disrupted pathways and imaging.

Main Results:

• A proposed classification divides MCD into four groups: megalencephaly/focal cortical dysplasia, tubulinopathies/lissencephalies, polymicrogyria syndromes, and heterotopia syndromes.
• Over 100 genes are linked to various MCD types, involving cell cycle regulation, neuronal migration, and cytoskeletal function.
• MCD are associated with diverse epileptic syndromes, from early-onset epileptic encephalopathies to focal epilepsies.

Conclusions:

• The proposed classification aids in understanding the genetic and biological mechanisms underlying MCD.
• Accurate diagnosis of MCD is crucial for managing refractory epilepsy in children.
• Further research into novel therapeutic strategies is essential to improve patient outcomes.